Rep. Lisa C. McClain Purchases Shares of West Pharmaceutical Services, Inc. (NYSE:WST)

Key Points

• Representative Lisa C. McClain purchased shares of West Pharmaceutical Services, Inc. (NYSE:WST) for an amount between $1,001 and $15,000 on June 17th, as disclosed in a filing.
• West Pharmaceutical Services recently reported $1.84 EPS for the quarter, exceeding expectations and showing a 9.2% year-over-year revenue increase.
• The company announced an increase in its quarterly dividend to $0.22 per share, up from the previous $0.21, with a dividend yield of 0.4%.

Representative Lisa C. McClain (R-Michigan) recently bought shares of West Pharmaceutical Services, Inc. NYSE: WST. In a filing disclosed on August 13th, the Representative disclosed that they had bought between $1,001 and $15,000 in West Pharmaceutical Services stock on June 17th. The trade occurred in the Representative's "CHARLES SCHWAB BROKERAGE ACCOUNT 924" account.

Representative Lisa C. McClain also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of Autoliv NYSE: ALV on 8/4/2025.
• Sold $1,001 - $15,000 in shares of Amazon.com NASDAQ: AMZN on 8/4/2025.
• Sold $1,001 - $15,000 in shares of Applied Materials NASDAQ: AMAT on 8/4/2025.
• Sold $1,001 - $15,000 in shares of Arthur J. Gallagher & Co. NYSE: AJG on 8/4/2025.
• Sold $1,001 - $15,000 in shares of SAP NYSE: SAP on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of XPO NYSE: XPO on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of Lithia Motors NYSE: LAD on 7/22/2025.
• Sold $1,001 - $15,000 in shares of Sanofi NASDAQ: SNY on 7/22/2025.
• Sold $1,001 - $15,000 in shares of Waters NYSE: WAT on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of Group 1 Automotive NYSE: GPI on 7/22/2025.

West Pharmaceutical Services Stock Performance

Shares of WST stock traded up $4.94 during trading hours on Friday, hitting $247.57. The stock had a trading volume of 503,627 shares, compared to its average volume of 682,039. The firm has a market capitalization of $17.80 billion, a PE ratio of 37.06, a PEG ratio of 4.40 and a beta of 1.05. West Pharmaceutical Services, Inc. has a twelve month low of $187.43 and a twelve month high of $352.33. The stock's 50 day moving average is $232.14 and its 200 day moving average is $225.37. The company has a debt-to-equity ratio of 0.07, a current ratio of 2.78 and a quick ratio of 2.08.

West Pharmaceutical Services (NYSE:WST - Get Free Report) last posted its quarterly earnings data on Thursday, July 24th. The medical instruments supplier reported $1.84 earnings per share for the quarter, beating the consensus estimate of $1.51 by $0.33. The business had revenue of $766.50 million during the quarter, compared to the consensus estimate of $725.11 million. West Pharmaceutical Services had a return on equity of 18.43% and a net margin of 16.48%.The company's revenue was up 9.2% compared to the same quarter last year. During the same period in the prior year, the company earned $1.52 earnings per share. West Pharmaceutical Services has set its FY 2025 guidance at 6.650-6.850 EPS. As a group, research analysts forecast that West Pharmaceutical Services, Inc. will post 6.62 earnings per share for the current fiscal year.

West Pharmaceutical Services Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, November 19th. Stockholders of record on Wednesday, November 12th will be issued a $0.22 dividend. The ex-dividend date of this dividend is Wednesday, November 12th. This is an increase from West Pharmaceutical Services's previous quarterly dividend of $0.21. This represents a $0.88 annualized dividend and a dividend yield of 0.4%. West Pharmaceutical Services's dividend payout ratio is currently 12.57%.

Institutional Trading of West Pharmaceutical Services

Large investors have recently made changes to their positions in the stock. Cerity Partners LLC boosted its stake in West Pharmaceutical Services by 1.7% in the 4th quarter. Cerity Partners LLC now owns 5,384 shares of the medical instruments supplier's stock worth $1,653,000 after buying an additional 90 shares during the last quarter. Bessemer Group Inc. boosted its stake in West Pharmaceutical Services by 11.8% in the 4th quarter. Bessemer Group Inc. now owns 748 shares of the medical instruments supplier's stock worth $245,000 after buying an additional 79 shares during the last quarter. Mariner LLC boosted its stake in West Pharmaceutical Services by 1.6% in the 4th quarter. Mariner LLC now owns 11,666 shares of the medical instruments supplier's stock worth $3,821,000 after buying an additional 183 shares during the last quarter. XTX Topco Ltd boosted its stake in West Pharmaceutical Services by 9.7% in the 4th quarter. XTX Topco Ltd now owns 1,167 shares of the medical instruments supplier's stock worth $382,000 after buying an additional 103 shares during the last quarter. Finally, Canada Post Corp Registered Pension Plan acquired a new stake in West Pharmaceutical Services in the 4th quarter worth about $434,000. Institutional investors and hedge funds own 93.90% of the company's stock.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on WST. Evercore ISI increased their price objective on West Pharmaceutical Services from $275.00 to $350.00 and gave the company an "outperform" rating in a report on Friday, July 25th. Wall Street Zen raised West Pharmaceutical Services from a "hold" rating to a "buy" rating in a report on Saturday, July 26th. Citigroup reaffirmed a "buy" rating on shares of West Pharmaceutical Services in a report on Thursday, May 22nd. Barclays assumed coverage on West Pharmaceutical Services in a report on Tuesday, June 24th. They set an "equal weight" rating and a $245.00 price target for the company. Finally, UBS Group increased their price objective on West Pharmaceutical Services from $285.00 to $320.00 and gave the stock a "buy" rating in a research report on Friday, July 25th. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat.com, West Pharmaceutical Services currently has a consensus rating of "Moderate Buy" and an average price target of $320.71.

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan's 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027. McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan's 9th Congressional District. She declared candidacy for the 2026 election. Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor's degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

About West Pharmaceutical Services

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.